Tumor Infiltrating Lymphocytes (TIL Cells) Transduced With An Interleukin-2 (SBIL-2) Gene Following The Administration Of A Nonmyeloablative But Lymphocyte Depleting Regimen in Metastatic Melanoma.
Latest Information Update: 07 Nov 2021
Price :
$35 *
At a glance
- Drugs Cyclophosphamide (Primary) ; Fludarabine (Primary) ; Tumour infiltrating lymphocytes (Primary) ; Filgrastim
- Indications Malignant melanoma
- Focus Therapeutic Use
- 26 Mar 2012 New trial record
- 26 Mar 2012 New trial record
- 17 Jul 2007 Planned number of patients 33 added as reported by ClinicalTrials.gov.